Ironwood Pharmaceuticals Falls 6% Following Disappointing Phase 2a Study
April 05, 2016 at 09:34 AM EDT
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) fell more than 6 percent early Tuesday morning after the company announced ...